Dame Esther Rantzen has issued a candid update on her health, following her diagnosis with stage four lung cancer two years ago. The broadcasting legend, who was at one point given just weeks to live, ...

for treating leptomeningeal metastases (“LM”) in patients with lung cancer. The stock continued to gain another 51.4% in after-hours trading following the news announcement. The FDA grants ODD ...

The EU approved AstraZeneca’s Imfinzi for limited-stage small cell lung cancer, reducing the risk ... Price Action: At the last check on Monday, AZN stock was down 1.04% to $76.78 during the ...

Under the terms of the deal, Servier will lead the development activities and the worldwide commercialization of BDTX-4933 across multiple indications, including non-small cell lung cancer ...